Potential use of magnesium oxide as an excipient to maintain the hardness of orally disintegrating tablets during unpackaged storage

6Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

This study aimed to clarify the effects of magnesium oxide (MgO) on the hardness of orally disintegrating tablets (ODTs) during storage. ODTs containing a range of MgO concentrations were prepared by direct powder compression and stored for up to 4 weeks in an unpackaged condition at 40°C, with 75% relative humidity. Tablets that did not contain MgO showed a significant decrease in hardness after one week in storage, while those containing MgO at a mass fraction of ≥4% maintained their hardness for up to 4 weeks. The tablet disintegration times after storage were equivalent to those observed before storage (approximately 30s), regardless of the MgO level. Furthermore, the dissolution behavior of a model drug (acetaminophen) from the ODTs was not affected by the level of MgO. These findings revealed that the addition of MgO suppressed the reduction in ODT hardness during storage in the unpackaged state, without delaying tablet disintegration or inhibiting drug release.

Cite

CITATION STYLE

APA

Sakamoto, T., Kachi, S., Nakamura, S., & Yuasa, H. (2019). Potential use of magnesium oxide as an excipient to maintain the hardness of orally disintegrating tablets during unpackaged storage. Chemical and Pharmaceutical Bulletin, 67(3), 284–288. https://doi.org/10.1248/cpb.c18-00588

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free